IXHL logo

IXHL Stock Overview

Profile

Full Name:

Incannex Healthcare Inc.

Sector:

Healthcare

Country:

Australia

IPO:

March 2, 2022

Indexes:

Not included

Description:

Incannex Healthcare Limited (IXHL) focuses on developing and commercializing innovative cannabinoid-based therapies. The company aims to address various medical conditions through research and clinical trials, leveraging the therapeutic potential of cannabis to improve patient outcomes and enhance healthcare solutions.

Events Calendar

Earnings

Next earnings date:

May 15, 2025

Recent quarterly earnings:

Feb 14, 2025

Recent annual earnings:

Sep 30, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Nov 30, 2023

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Incannex Healthcare Limited?
  • Does Incannex Healthcare Limited pay dividends?
  • What sector is Incannex Healthcare Limited in?
  • What industry is Incannex Healthcare Limited in?
  • What country is Incannex Healthcare Limited based in?
  • When did Incannex Healthcare Limited go public?
  • Is Incannex Healthcare Limited in the S&P 500?
  • Is Incannex Healthcare Limited in the NASDAQ 100?
  • Is Incannex Healthcare Limited in the Dow Jones?
  • When was Incannex Healthcare Limited's last earnings report?
  • When does Incannex Healthcare Limited report earnings?
  • Should I buy Incannex Healthcare Limited stock now?

What is the ticker symbol for Incannex Healthcare Limited?

The ticker symbol for Incannex Healthcare Limited is NASDAQ:IXHL

Does Incannex Healthcare Limited pay dividends?

No, Incannex Healthcare Limited does not pay dividends

What sector is Incannex Healthcare Limited in?

Incannex Healthcare Limited is in the Healthcare sector

What industry is Incannex Healthcare Limited in?

Incannex Healthcare Limited is in the Drug Manufacturers - Specialty & Generic industry

What country is Incannex Healthcare Limited based in?

Incannex Healthcare Limited is headquartered in Australia

When did Incannex Healthcare Limited go public?

Incannex Healthcare Limited's initial public offering (IPO) was on March 2, 2022

Is Incannex Healthcare Limited in the S&P 500?

No, Incannex Healthcare Limited is not included in the S&P 500 index

Is Incannex Healthcare Limited in the NASDAQ 100?

No, Incannex Healthcare Limited is not included in the NASDAQ 100 index

Is Incannex Healthcare Limited in the Dow Jones?

No, Incannex Healthcare Limited is not included in the Dow Jones index

When was Incannex Healthcare Limited's last earnings report?

Incannex Healthcare Limited's most recent earnings report was on Feb 14, 2025

When does Incannex Healthcare Limited report earnings?

The next expected earnings date for Incannex Healthcare Limited is May 15, 2025

Should I buy Incannex Healthcare Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions